Ortho Clinical Diagnostics Inc Rochester, NY - 14606

Ortho Clinical Diagnostics Inc is categorized under Blood Derivative Diagnostic Agents in Rochester, NY .

Ortho Clinical Diagnostics Inc was established in 0, and today employs 1 to 4, earning $10.000.000 to $19.9999.999 per year. This is a Blood Derivative Diagnostic Agents business, which does work in the B2B market, and is classified as a Blood Derivative Diagnostic Agents, under code number 6215110 by the NAICS.

If you are seeking more information, feel free to contact David Cress at the company’s branch by writing to 1000 Lee Road, Rochester, New York NY 14606 or by phoning (585) 453-6066. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Ortho Clinical Diagnostics Inc
Contact Person: David Cress
Address: 1000 Lee Road, Rochester, New York 14606
Phone Number: (585) 453-6066
Website Address: orthoclinical.com
Annual Revenue (USD): $10.000.000 to $19.9999.999
Location Type: Branch
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Blood Derivative Diagnostic Agents
SIC Code: 2835
NAICS Code: 6215110
Share This Business:

Ortho Clinical Diagnostics Inc was started in 0 to provide professional Blood Derivative Diagnostic Agents under the SIC code 2835 and NAICS code 6215110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $10.000.000 to $19.9999.999 per annum.

Feel free to contact David Cress for inquiries that concern Ortho Clinical Diagnostics Inc by calling the company number (585) 453-6066, as your correspondence is most welcome. Additionally, the physical location of the branch of Ortho Clinical Diagnostics Inc can be found at the coordinates 43.16946,-77.68395 as well as the street address 1000 Lee Road in Rochester, New York 14606.

For its online presence, you may visit Ortho Clinical Diagnostics Inc’s website at orthoclinical.com and engage with its social media outlets through on Twitter and on Facebook.